Full-Time
Offers preventive health assessments and monitoring
$155k - $185k/yr
Senior
San Carlos, CA, USA
Position requires onsite presence in San Carlos.
Q.bio focuses on preventive medicine by identifying early signs of disease before symptoms arise, which allows for timely interventions and improved health outcomes. The company offers a health assessment called the Q Exam, which lasts about an hour and collects data from blood, saliva, urine, vital signs, and whole-body MRI scans. This information is stored securely in a personalized BioVault and can be accessed through a web-based Q Dashboard, designed for telemedicine, enabling users to share their health data with healthcare professionals globally. Q.bio operates on a subscription model, allowing individuals to become members for regular health assessments and continuous monitoring, while also partnering with clinicians to enhance their practices with data-driven preventive care. The goal of Q.bio is to empower clients to take control of their health through detailed assessments that facilitate early disease detection.
Company Size
11-50
Company Stage
Late Stage VC
Total Funding
$67M
Headquarters
San Carlos, California
Founded
2015
Help us improve and share your feedback! Did you find this helpful?
Performance Bonus
Q Bio Secures $27M to Expand Full-Body MRI with Mark I Scanner. by Fred Pennic 07/18/2024 Leave a Comment. <img src="https://hitconsultant.net/wp-content/uploads/2024/07/Xnip2024-07-18_09-49-05-1500x694.jpg" alt="
Q Bio raises $27M in funding round for Mark I MRI scanner.
PALO ALTO, Calif.--(BUSINESS WIRE)--Q Bio Inc., an innovator in medical imaging technology, today announced the launch of Tensor Field Mapping (TFM), a new technology for Magnetic Resonance Imaging (MRI) that provides detailed insights into the human body that were previously unimaginable. Unlike traditional MRIs that provide qualitative data prone to machine or clinical variations, TFM delivers quantitative, harmonized imaging data that can be immediately accessed by AI to accelerate diagnostics. "For decades, MRI technology has been invaluable in diagnosing a wide range of medical conditions, yet it has been limited by its qualitative nature and the variability of the data," said Jeff Kaditz, Founder and CTO / CEO, Q Bio. "With the introduction of Tensor Field Mapping, we are taking a quantum leap forward, making multi-parametric quantification of tissues reproducible across machines, which is key to AI in MRI and personalized medicine.". TFM is the result of extensive research and development by Q Bio's team of experts in medical imaging, physics, and computational science, and will make its debut in the company’s upcoming Mark I full body scanner. The technology provides quantifiable data lacking in traditional MRIs so that properties of tissues can be measured and benchmarked on an ongoing basis
Medical imaging company Q Bio announced the launch of a multiparametric MRI upgrade, dubbed Tensor Field Mapping (TFM), designed to provide more detail into the inner-workings of the human body than are currently possible with an MR scanner.
Q Bio launches multiparametric MRI quantification softwre.